AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2011
Feb 24, 2011
30339_dirs_2011-02-24_db7e8e3e-a098-41f5-8e0a-da7ccdd62cd4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2011-02-22
Reporting Person: ELLERS STEVEN A (COO & President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-02-22 | Common Stock | A | 4585.0000 | $40.8500 | Acquired | 156543.8728 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3498.2821 | Indirect |
| Common Stock | 20414.5077 | Indirect |
Footnotes
F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2008 that have vested for performance period 7.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27